The role of peroxisome proliferator-activated receptor β/δ in colorectal cancer
Peroxisome proliferator–activated receptor β/δ (PPAR β/δ) is overexpressed in human colon cancer, but its contribution to colonic tumorigenesis is controversial. We generated a mouse model in which PPARβ/δ was genetically disrupted in the fibroblasts (FSPCre-Pparb/d-/-). FSPCre-Pparb/d-/- mice were...
Saved in:
Main Author: | |
---|---|
Other Authors: | |
Format: | Theses and Dissertations |
Language: | English |
Published: |
2018
|
Subjects: | |
Online Access: | http://hdl.handle.net/10356/74230 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Summary: | Peroxisome proliferator–activated receptor β/δ (PPAR β/δ) is overexpressed in human colon cancer, but its contribution to colonic tumorigenesis is controversial. We generated a mouse model in which PPARβ/δ was genetically disrupted in the fibroblasts (FSPCre-Pparb/d-/-). FSPCre-Pparb/d-/- mice were less susceptible to DSS-induced colitis, developed fewer intestinal polyps and survived longer when compared with Pparb/dfl/fl mice. Comparative gene expression analysis of epithelial and mucosal layers revealed enhanced NRF2-mediated stress responses in intestinal epithelium owing to the deletion of fibroblast PPARβ/δ. The pre-treatment of FSPCre-Pparb/d−/− and Pparb/dfl/fl with antioxidant N-acetyl-cysteine prior DSS-induced tumorigenesis resulted in lower tumor load. |
---|